Retinal ciliopathy due to mutation in Usher gene

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:156177
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Retinal ciliopathy due to mutation in Usher gene (Orphanet code 156177) refers to a group of inherited retinal dystrophies caused by mutations in genes typically associated with Usher syndrome, but presenting primarily or exclusively with retinal involvement (retinitis pigmentosa) without the sensorineural hearing loss that characterizes classic Usher syndrome. Usher syndrome genes encode proteins critical for the structure and function of cilia in photoreceptor cells and hair cells of the inner ear. When mutations in these genes selectively or predominantly affect retinal photoreceptor cilia, patients develop progressive rod-cone dystrophy (retinitis pigmentosa) leading to night blindness, progressive visual field constriction, and eventual central vision loss, while hearing may be normal or only mildly affected. The retinal degeneration in this condition results from dysfunction of the photoreceptor connecting cilium, which is essential for transporting proteins between the inner and outer segments of rod and cone cells. Affected individuals typically present with nyctalopia (night blindness) in childhood or adolescence, followed by progressive peripheral visual field loss and eventual decline in central visual acuity. Fundoscopic examination reveals characteristic bone-spicule pigmentation, attenuated retinal vessels, and waxy pallor of the optic disc. Electroretinography (ERG) shows diminished or absent rod and cone responses. Currently, there is no curative treatment for this condition. Management is primarily supportive and includes regular ophthalmologic monitoring, low-vision aids, orientation and mobility training, and genetic counseling. Vitamin A supplementation has been suggested in some forms of retinitis pigmentosa, though evidence remains limited. Gene therapy approaches are under active investigation for several forms of Usher-related retinal disease, and clinical trials are ongoing for specific gene targets. Patients should also be monitored for potential subclinical hearing changes given the involvement of Usher syndrome genes.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Retinal ciliopathy due to mutation in Usher gene.

View clinical trials →

No actively recruiting trials found for Retinal ciliopathy due to mutation in Usher gene at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Retinal ciliopathy due to mutation in Usher gene community →

No specialists are currently listed for Retinal ciliopathy due to mutation in Usher gene.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Retinal ciliopathy due to mutation in Usher gene.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Retinal ciliopathy due to mutation in Usher geneForum →

No community posts yet. Be the first to share your experience with Retinal ciliopathy due to mutation in Usher gene.

Start the conversation →

Latest news about Retinal ciliopathy due to mutation in Usher gene

No recent news articles for Retinal ciliopathy due to mutation in Usher gene.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Retinal ciliopathy due to mutation in Usher gene

What is Retinal ciliopathy due to mutation in Usher gene?

Retinal ciliopathy due to mutation in Usher gene (Orphanet code 156177) refers to a group of inherited retinal dystrophies caused by mutations in genes typically associated with Usher syndrome, but presenting primarily or exclusively with retinal involvement (retinitis pigmentosa) without the sensorineural hearing loss that characterizes classic Usher syndrome. Usher syndrome genes encode proteins critical for the structure and function of cilia in photoreceptor cells and hair cells of the inner ear. When mutations in these genes selectively or predominantly affect retinal photoreceptor cilia,

How is Retinal ciliopathy due to mutation in Usher gene inherited?

Retinal ciliopathy due to mutation in Usher gene follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.